The ACR (albumin-to-creatine ratio) is a significant prognostic marker for CKD patients [14,15] and is widely used as an early indicator of glomerular lesions [16,17,18] and for the on-going monitoring of diabetes and hypertension [19,20]. The gene discussed is ALB; the disease is chronic kidney disease.